Bill Text: OH HB547 | 2009-2010 | 128th General Assembly | Introduced


Bill Title: To establish licensing requirements for pain management clinics and to modify the laws governing the Ohio Automated Rx Reporting System.

Spectrum: Partisan Bill (Democrat 4-0)

Status: (Introduced - Dead) 2010-06-09 - To Health [HB547 Detail]

Download: Ohio-2009-HB547-Introduced.html
As Introduced

128th General Assembly
Regular Session
2009-2010
H. B. No. 547


Representatives Garland, Pryor 

Cosponsors: Representatives Domenick, Harris 



A BILL
To amend sections 4723.481, 4729.071, 4729.51, 1
4729.54, 4729.541, 4729.55, 4729.78, 4729.79, 2
4729.81, 4729.82, 4729.99, 4731.052, 4731.22, 3
4731.283, 4776.02, and 4776.04 and to enact 4
sections 4729.552, 4729.561, 4729.571, 4729.85, 5
4731.054, 4731.055, 4731.228, and 4731.241 of the 6
Revised Code to establish licensing requirements 7
for pain management clinics and to modify the laws 8
governing the Ohio Automated Rx Reporting System.9


BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF OHIO:

       Section 1. That sections 4723.481, 4729.071, 4729.51, 10
4729.54, 4729.541, 4729.55, 4729.78, 4729.79, 4729.81, 4729.82, 11
4729.99, 4731.052, 4731.22, 4731.283, 4776.02, and 4776.04 be 12
amended and sections 4729.552, 4729.561, 4729.571, 4729.85, 13
4731.054, 4731.055, 4731.228, and 4731.241 of the Revised Code be 14
enacted to read as follows:15

       Sec. 4723.481.  Under a certificate to prescribe issued under 16
section 4723.48 of the Revised Code, a clinical nurse specialist, 17
certified nurse-midwife, or certified nurse practitioner is 18
subject to all of the following:19

       (A) The nurse shall not prescribe any drug or therapeutic 20
device that is not included in the types of drugs and devices 21
listed on the formulary established in rules adopted under section 22
4723.50 of the Revised Code.23

       (B) The nurse's prescriptive authority shall not exceed the 24
prescriptive authority of the collaborating physician or 25
podiatrist and shall be in conformance with any rules adopted by 26
the state medical board under Chapter 4731. of the Revised Code 27
governing physician or podiatrist prescribing.28

       (C) The nurse may prescribe a schedule II controlled 29
substance as specified in division (A)(2) of section 3719.06 of 30
the Revised Code, but shall not prescribe a schedule II controlled 31
substance in collaboration with a podiatrist.32

       (D) The nurse may personally furnish to a patient a sample of 33
any drug or therapeutic device included in the types of drugs and 34
devices listed on the formulary, subject to all of the following:35

       (1) The amount of the sample furnished shall not exceed a 36
seventy-two-hour supply, except when the minimum available 37
quantity of the sample is packaged in an amount that is greater 38
than a seventy-two-hour supply, in which case the nurse may 39
furnish the sample in the packaged amount.40

       (2) No charge may be imposed for the sample or for furnishing 41
it.42

       (3) Samples of controlled substances may not be personally 43
furnished.44

       (E) The nurse may personally furnish to a patient a complete 45
or partial supply of a drug or therapeutic device included in the 46
types of drugs and devices listed on the formulary, subject to all 47
of the following:48

       (1) The nurse shall personally furnish only antibiotics, 49
antifungals, scabicides, contraceptives, prenatal vitamins, 50
antihypertensives, drugs and devices used in the treatment of 51
diabetes, drugs and devices used in the treatment of asthma, and 52
drugs used in the treatment of dyslipidemia.53

       (2) The nurse shall not furnish the drugs and devices in 54
locations other than a health department operated by the board of 55
health of a city or general health district or the authority 56
having the duties of a board of health under section 3709.05 of 57
the Revised Code, a federally funded comprehensive primary care 58
clinic, or a nonprofit health care clinic or program.59

       (3) The nurse shall comply with all safety standards for 60
personally furnishing supplies of drugs and devices, as 61
established in rules adopted under section 4723.50 of the Revised 62
Code.63

       Sec. 4729.071.  (A) As used in this section, "license" and 64
"applicant for an initial license" have the same meanings as in 65
section 4776.01 of the Revised Code, except that "license" as used 66
in both of those terms refers to the types of authorizations 67
otherwise issued or conferred under this chapter.68

       (B) In addition to any other eligibility requirement set 69
forth in this chapter, each applicant for an initial license shall 70
comply with sections 4776.01 to 4776.04 of the Revised Code. The 71
state board of pharmacy shall not grant a license to an applicant 72
for an initial license unless the applicant complies with sections 73
4776.01 to 4776.04 of the Revised Code and the board, in its 74
discretion, decides that the results of the criminal records check 75
do not make the applicant ineligible for a license issued pursuant 76
to section 4729.08, 4729.09, or 4729.11, or 4729.552 of the 77
Revised Code.78

       Sec. 4729.51.  (A) No person other than a registered 79
wholesale distributor of dangerous drugs shall possess for sale, 80
sell, distribute, or deliver, at wholesale, dangerous drugs, 81
except as follows:82

       (1) A pharmacist who is a licensed terminal distributor of 83
dangerous drugs or who is employed by a licensed terminal 84
distributor of dangerous drugs may make occasional sales of 85
dangerous drugs at wholesale;86

       (2) A licensed terminal distributor of dangerous drugs having 87
more than one establishment or place may transfer or deliver 88
dangerous drugs from one establishment or place for which a 89
license has been issued to the terminal distributor to another 90
establishment or place for which a license has been issued to the 91
terminal distributor if the license issued for each establishment 92
or place is in effect at the time of the transfer or delivery.93

       (B)(1) No registered wholesale distributor of dangerous drugs 94
shall possess for sale, or sell, at wholesale, dangerous drugs to 95
any person other than the following:96

       (a) A licensed health professional authorized to prescribe 97
drugs, except that a wholesale distributor of dangerous drugs may 98
not possess for sale, or sell, at wholesale, dangerous drugs to a 99
licensed health professional authorized to prescribe drugs if the 100
professional is employed by a pain management clinic, as defined 101
in section 4731.054 of the Revised Code, that is not licensed as a 102
terminal distributor of dangerous drugs with a pain management 103
clinic classification under section 4729.552 of the Revised Code;104

       (b) An optometrist licensed under Chapter 4725. of the 105
Revised Code who holds a topical ocular pharmaceutical agents 106
certificate;107

       (c) A registered wholesale distributor of dangerous drugs;108

       (d) A manufacturer of dangerous drugs;109

       (e) A licensed terminal distributor of dangerous drugs, 110
subject to division (B)(2) of this section;111

       (f) Carriers or warehousers for the purpose of carriage or 112
storage;113

       (g) Terminal or wholesale distributors of dangerous drugs who 114
are not engaged in the sale of dangerous drugs within this state;115

       (h) An individual who holds a current license, certificate, 116
or registration issued under Title 47 of the Revised Code and has 117
been certified to conduct diabetes education by a national 118
certifying body specified in rules adopted by the state board of 119
pharmacy under section 4729.68 of the Revised Code, but only with 120
respect to insulin that will be used for the purpose of diabetes 121
education and only if diabetes education is within the 122
individual's scope of practice under statutes and rules regulating 123
the individual's profession;124

       (i) An individual who holds a valid certificate issued by a 125
nationally recognized S.C.U.B.A. diving certifying organization 126
approved by the pharmacy board in rule, but only with respect to 127
medical oxygen that will be used for the purpose of emergency care 128
or treatment at the scene of a diving emergency;129

       (j) A business entity that is a corporation formed under 130
division (B) of section 1701.03 of the Revised Code, a limited 131
liability company formed under Chapter 1705. of the Revised Code, 132
or a professional association formed under Chapter 1785. of the 133
Revised Code if the entity has a sole shareholder who is a 134
licensed health professional authorized to prescribe drugs and is 135
authorized to provide the professional services being offered by 136
the entity, except that a wholesale distributor of dangerous drugs 137
may not possess for sale, or sell, at wholesale, dangerous drugs 138
to an entity described in division (B)(1)(j) of this section if 139
the entity is a pain management clinic, as defined in section 140
4731.054 of the Revised Code, that is not licensed as a terminal 141
distributor of dangerous drugs with a pain management clinic 142
classification under section 4729.552 of the Revised Code;143

        (k) A business entity that is a corporation formed under 144
division (B) of section 1701.03 of the Revised Code, a limited 145
liability company formed under Chapter 1705. of the Revised Code, 146
a partnership or a limited liability partnership formed under 147
Chapter 1775. of the Revised Code, or a professional association 148
formed under Chapter 1785. of the Revised Code, if, to be a 149
shareholder, member, or partner, an individual is required to be 150
licensed, certified, or otherwise legally authorized under Title 151
XLVII of the Revised Code to perform the professional service 152
provided by the entity and each such individual is a licensed 153
health professional authorized to prescribe drugs, except that a 154
wholesale distributor of dangerous drugs may not possess for sale, 155
or sell, at wholesale, dangerous drugs to an entity described in 156
division (B)(1)(k) of this section if the entity is a pain 157
management clinic, as defined in section 4731.054 of the Revised 158
Code, that is not licensed as a terminal distributor of dangerous 159
drugs with a pain management clinic classification under section 160
4729.552 of the Revised Code.161

       (2) No registered wholesale distributor of dangerous drugs 162
shall possess dangerous drugs for sale at wholesale, or sell such 163
drugs at wholesale, to a licensed terminal distributor of 164
dangerous drugs, except to:165

       (a) A terminal distributor who has a category I license, only 166
dangerous drugs described in category I, as defined in division 167
(A)(1) of section 4729.54 of the Revised Code;168

       (b) A terminal distributor who has a category II license, 169
only dangerous drugs described in category I and category II, as 170
defined in divisions (A)(1) and (2) of section 4729.54 of the 171
Revised Code;172

       (c) A terminal distributor who has a category III license, 173
dangerous drugs described in category I, category II, and category 174
III, as defined in divisions (A)(1), (2), and (3) of section 175
4729.54 of the Revised Code;176

       (d) A terminal distributor who has a limited category I, II, 177
or III license, only the dangerous drugs specified in the 178
certificate furnished by the terminal distributor in accordance 179
with section 4729.60 of the Revised Code.180

       (C)(1) Except as provided in division (C)(4) of this section, 181
no person shall sell, at retail, dangerous drugs.182

       (2) Except as provided in division (C)(4) of this section, no 183
person shall possess for sale, at retail, dangerous drugs.184

       (3) Except as provided in division (C)(4) of this section, no 185
person shall possess dangerous drugs.186

       (4) Divisions (C)(1), (2), and (3) of this section do not 187
apply to a registered wholesale distributor of dangerous drugs, a 188
licensed terminal distributor of dangerous drugs, or a person who 189
possesses, or possesses for sale or sells, at retail, a dangerous 190
drug in accordance with Chapters 3719., 4715., 4723., 4725., 191
4729., 4730., 4731., and 4741. of the Revised Code.192

       Divisions (C)(1), (2), and (3) of this section do not apply 193
to an individual who holds a current license, certificate, or 194
registration issued under Title XLVII of the Revised Code and has 195
been certified to conduct diabetes education by a national 196
certifying body specified in rules adopted by the state board of 197
pharmacy under section 4729.68 of the Revised Code, but only to 198
the extent that the individual possesses insulin or personally 199
supplies insulin solely for the purpose of diabetes education and 200
only if diabetes education is within the individual's scope of 201
practice under statutes and rules regulating the individual's 202
profession.203

       Divisions (C)(1), (2), and (3) of this section do not apply 204
to an individual who holds a valid certificate issued by a 205
nationally recognized S.C.U.B.A. diving certifying organization 206
approved by the pharmacy board in rule, but only to the extent 207
that the individual possesses medical oxygen or personally 208
supplies medical oxygen for the purpose of emergency care or 209
treatment at the scene of a diving emergency.210

       (D) No licensed terminal distributor of dangerous drugs shall 211
purchase for the purpose of resale dangerous drugs from any person 212
other than a registered wholesale distributor of dangerous drugs, 213
except as follows:214

       (1) A licensed terminal distributor of dangerous drugs may 215
make occasional purchases of dangerous drugs for resale from a 216
pharmacist who is a licensed terminal distributor of dangerous 217
drugs or who is employed by a licensed terminal distributor of 218
dangerous drugs;219

       (2) A licensed terminal distributor of dangerous drugs having 220
more than one establishment or place may transfer or receive 221
dangerous drugs from one establishment or place for which a 222
license has been issued to the terminal distributor to another 223
establishment or place for which a license has been issued to the 224
terminal distributor if the license issued for each establishment 225
or place is in effect at the time of the transfer or receipt.226

       (E) No licensed terminal distributor of dangerous drugs shall 227
engage in the sale or other distribution of dangerous drugs at 228
retail or maintain possession, custody, or control of dangerous 229
drugs for any purpose other than the distributor's personal use or 230
consumption, at any establishment or place other than that or 231
those described in the license issued by the board of pharmacy to 232
such terminal distributor.233

       (F) Nothing in this section shall be construed to interfere 234
with the performance of official duties by any law enforcement 235
official authorized by municipal, county, state, or federal law to 236
collect samples of any drug, regardless of its nature or in whose 237
possession it may be.238

       Sec. 4729.54.  (A) As used in this section and section239
sections 4729.541, 4729.55, and 4729.552 of the Revised Code:240

       (1) "Category I" means single-dose injections of intravenous 241
fluids, including saline, Ringer's lactate, five per cent dextrose 242
and distilled water, and other intravenous fluids or parenteral 243
solutions included in this category by rule of the state board of 244
pharmacy, that have a volume of one hundred milliliters or more 245
and that contain no added substances, or single-dose injections of 246
epinephrine to be administered pursuant to sections 4765.38 and 247
4765.39 of the Revised Code.248

       (2) "Category II" means any dangerous drug that is not 249
included in category I or III.250

       (3) "Category III" means any controlled substance that is 251
contained in schedule I, II, III, IV, or V.252

       (4) "Emergency medical service organization" has the same 253
meaning as in section 4765.01 of the Revised Code.254

       (5) "Person" includes an emergency medical service 255
organization.256

       (6) "Schedule I, schedule II, schedule III, schedule IV, and 257
schedule V" mean controlled substance schedules I, II, III, IV, 258
and V, respectively, as established pursuant to section 3719.41 of 259
the Revised Code and as amended.260

       (7) "Pain management clinic" has the same meaning as in 261
section 4731.054 of the Revised Code.262

       (B)(1) A person who desires to be licensed as a terminal 263
distributor of dangerous drugs shall file with the executive 264
director of the state board of pharmacy a verified application 265
that contains the following:266

       (1)(a) Information that the board requires relative to the 267
qualifications of a terminal distributor of dangerous drugs set 268
forth in section 4729.55 of the Revised Code;269

       (2)(b) A statement that the person wishes to be licensed as a 270
category I, category II, category III, limited category I, limited 271
category II, or limited category III terminal distributor of 272
dangerous drugs;273

       (3)(c) If the person wishes to be licensed as a limited 274
category I, limited category II, or limited category III terminal 275
distributor of dangerous drugs, a notarized list of the dangerous 276
drugs that the person wishes to possess, have custody or control 277
of, and distribute, which list shall also specify the purpose for 278
which those drugs will be used and their source;279

       (4)(d) If the person is an emergency medical service 280
organization, the information that is specified in division (C)(1) 281
of this section;282

       (5)(e) Except for an emergency medical service organization, 283
the identity of the one establishment or place at which the person 284
intends to engage in the sale or other distribution of dangerous 285
drugs at retail, and maintain possession, custody, or control of 286
dangerous drugs for purposes other than the person's own use or 287
consumption;288

       (f) If the application pertains to a pain management clinic, 289
information that demonstrates, to the satisfaction of the board, 290
compliance with division (A) of section 4729.552 of the Revised 291
Code.292

       (2) An application for a license as a terminal distributor of 293
dangerous drugs may not be withdrawn unless approved by the board.294

       (C)(1) An emergency medical service organization that wishes 295
to be licensed as a terminal distributor of dangerous drugs shall 296
list in its application for licensure the following additional 297
information:298

       (a) The units under its control that the organization 299
determines will possess dangerous drugs for the purpose of 300
administering emergency medical services in accordance with 301
Chapter 4765. of the Revised Code;302

       (b) With respect to each such unit, whether the dangerous 303
drugs that the organization determines the unit will possess are 304
in category I, II, or III.305

       (2) An emergency medical service organization that is 306
licensed as a terminal distributor of dangerous drugs shall file a 307
new application for such licensure if there is any change in the 308
number, or location of, any of its units or any change in the 309
category of the dangerous drugs that any unit will possess.310

       (3) A unit listed in an application for licensure pursuant to 311
division (C)(1) of this section may obtain the dangerous drugs it 312
is authorized to possess from its emergency medical service 313
organization or, on a replacement basis, from a hospital pharmacy. 314
If units will obtain dangerous drugs from a hospital pharmacy, the 315
organization shall file, and maintain in current form, the 316
following items with the pharmacist who is responsible for the 317
hospital's terminal distributor of dangerous drugs license:318

       (a) A copy of its standing orders or protocol;319

       (b) A list of the personnel employed or used by the 320
organization to provide emergency medical services in accordance 321
with Chapter 4765. of the Revised Code, who are authorized to 322
possess the drugs, which list also shall indicate the personnel 323
who are authorized to administer the drugs.324

       (D) Each emergency medical service organization that applies 325
for a terminal distributor of dangerous drugs license shall submit 326
with its application the following:327

       (1) A notarized copy of its standing orders or protocol, 328
which orders or protocol shall be signed by a physician and 329
specify the dangerous drugs that its units may carry, expressed in 330
standard dose units;331

       (2) A list of the personnel employed or used by the 332
organization to provide emergency medical services in accordance 333
with Chapter 4765. of the Revised Code.334

       An emergency medical service organization that is licensed as 335
a terminal distributor shall notify the board immediately of any 336
changes in its standing orders or protocol.337

       (E) There shall be six categories of terminal distributor of 338
dangerous drugs licenses, which categories shall be as follows:339

       (1) Category I license. A person who obtains this license may 340
possess, have custody or control of, and distribute only the 341
dangerous drugs described in category I.342

       (2) Limited category I license. A person who obtains this 343
license may possess, have custody or control of, and distribute 344
only the dangerous drugs described in category I that were listed 345
in the application for licensure.346

       (3) Category II license. A person who obtains this license 347
may possess, have custody or control of, and distribute only the 348
dangerous drugs described in category I and category II.349

       (4) Limited category II license. A person who obtains this 350
license may possess, have custody or control of, and distribute 351
only the dangerous drugs described in category I or category II 352
that were listed in the application for licensure.353

       (5) Category III license. A person who obtains this license 354
may possess, have custody or control of, and distribute the 355
dangerous drugs described in category I, category II, and category 356
III.357

       (6) Limited category III license. A person who obtains this 358
license may possess, have custody or control of, and distribute 359
only the dangerous drugs described in category I, category II, or 360
category III that were listed in the application for licensure.361

       (F) Except for an application made on behalf of an animal 362
shelter, if an applicant for licensure as a limited category I, 363
II, or III terminal distributor of dangerous drugs intends to 364
administer dangerous drugs to a person or animal, the applicant 365
shall submit, with the application, a notarized copy of its 366
protocol or standing orders, which protocol or orders shall be 367
signed by a licensed health professional authorized to prescribe 368
drugs, specify the dangerous drugs to be administered, and list 369
personnel who are authorized to administer the dangerous drugs in 370
accordance with federal law or the law of this state. An 371
application made on behalf of an animal shelter shall include a 372
notarized list of the dangerous drugs to be administered to 373
animals and the personnel who are authorized to administer the 374
drugs to animals in accordance with section 4729.532 of the 375
Revised Code. After obtaining a terminal distributor license, a 376
licensee shall notify the board immediately of any changes in its 377
protocol or standing orders, or in such personnel.378

       (G)(1) Except as provided in division (G)(2) of this section, 379
each applicant for licensure as a terminal distributor of 380
dangerous drugs shall submit, with the application, a license fee 381
determined as follows:382

       (a) For a category I or limited category I license, 383
forty-five dollars;384

       (b) For a category II or limited category II license, one 385
hundred twelve dollars and fifty cents;386

       (c) For a category III or limited category III license, 387
including for applicants classified as a pain management clinic 388
under section 4729.552 of the Revised Code, one hundred fifty 389
dollars.390

       (2) For a professional association, corporation, partnership, 391
or limited liability company organized for the purpose of 392
practicing veterinary medicine, the fee shall be forty dollars.393

       Fees assessed under divisions (G)(1) and (2) of this section 394
shall not be returned if the applicant fails to qualify for 395
registration.396

       (H)(1) The board shall issue a terminal distributor of 397
dangerous drugs license to each person who submits an application 398
for such licensure in accordance with this section, pays the 399
required license fee, is determined by the board to meet the 400
requirements set forth in section 4729.55 of the Revised Code, and 401
satisfies any other applicable requirements of this section.402

       (2) The license of a person other than an emergency medical 403
service organization shall describe the one establishment or place 404
at which the licensee may engage in the sale or other distribution 405
of dangerous drugs at retail and maintain possession, custody, or 406
control of dangerous drugs for purposes other than the licensee's 407
own use or consumption. The one establishment or place shall be 408
that which is described in the application for licensure.409

       No such license shall authorize or permit the terminal 410
distributor of dangerous drugs named in it to engage in the sale 411
or other distribution of dangerous drugs at retail or to maintain 412
possession, custody, or control of dangerous drugs for any purpose 413
other than the distributor's own use or consumption, at any 414
establishment or place other than that described in the license, 415
except that an agent or employee of an animal shelter may possess 416
and use dangerous drugs in the course of business as provided in 417
division (D) of section 4729.532 of the Revised Code.418

       (3) The license of an emergency medical service organization 419
shall cover and describe all the units of the organization listed 420
in its application for licensure.421

       (4) The license of every terminal distributor of dangerous 422
drugs shall indicate, on its face, the category of licensure. If 423
the license is a limited category I, II, or III license, it shall 424
specify, and shall authorize the licensee to possess, have custody 425
or control of, and distribute only, the dangerous drugs that were 426
listed in the application for licensure.427

       (I) All licenses issued pursuant to this section shall be 428
effective for a period of twelve months from the first day of 429
January of each year. A license shall be renewed by the board for 430
a like period, annually, according to the provisions of this 431
section, and the standard renewal procedure of Chapter 4745. of 432
the Revised Code. A person who desires to renew a license shall 433
submit an application for renewal and pay the required fee on or 434
before the thirty-first day of December each year. The fee 435
required for the renewal of a license shall be the same as the fee 436
paid for the license being renewed, and shall accompany the 437
application for renewal.438

       A license that has not been renewed during December in any 439
year and by the first day of February of the following year may be 440
reinstated only upon payment of the required renewal fee and a 441
penalty fee of fifty-five dollars.442

       (J)(1) No emergency medical service organization that is 443
licensed as a terminal distributor of dangerous drugs shall fail 444
to comply with division (C)(2) or (3) of this section.445

       (2) No emergency medical service organization that is 446
licensed as a terminal distributor of dangerous drugs shall fail 447
to comply with division (D) of this section.448

       (3) No licensed terminal distributor of dangerous drugs shall 449
possess, have custody or control of, or distribute dangerous drugs 450
that the terminal distributor is not entitled to possess, have 451
custody or control of, or distribute by virtue of its category of 452
licensure.453

       (4) No licensee that is required by division (F) of this 454
section to notify the board of changes in its protocol or standing 455
orders, or in personnel, shall fail to comply with that division.456

       Sec. 4729.541. A person(A) Except as provided in division 457
(B) of this section, an entity described in division (B)(1)(j) or 458
(k) of section 4729.51 of the Revised Code may possess, have 459
custody or control of, and distribute the dangerous drugs in 460
category I, category II, and category III of section 4729.54 of 461
the Revised Code without holding a terminal distributor of 462
dangerous drugs license issued under that section.463

       (B) Division (A) of this section does not apply to an entity 464
described in division (B)(1)(j) or (k) of section 4729.51 of the 465
Revised Code that is a pain management clinic.466

       Sec. 4729.55.  No license shall be issued to an applicant for 467
licensure as a terminal distributor of dangerous drugs unless the 468
applicant has furnished satisfactory proof to the state board of 469
pharmacy that:470

       (A) The applicant is equipped as to land, buildings, and 471
equipment to properly carry on the business of a terminal 472
distributor of dangerous drugs within the category of licensure 473
approved by the board.474

       (B) A pharmacist, licensed health professional authorized to 475
prescribe drugs, animal shelter licensed with the state board of 476
pharmacy under section 4729.531 of the Revised Code, or a 477
laboratory as defined in section 3719.01 of the Revised Code will 478
maintain supervision and control over the possession and custody 479
of dangerous drugs that may be acquired by or on behalf of the 480
applicant.481

       (C) Adequate safeguards are assured to prevent the sale or 482
other distribution of dangerous drugs by any person other than a 483
pharmacist or licensed health professional authorized to prescribe 484
drugs.485

       (D) Adequate safeguards are assured that the applicant will 486
carry on the business of a terminal distributor of dangerous drugs 487
in a manner that allows pharmacists and pharmacy interns employed 488
by the terminal distributor to practice pharmacy in a safe and 489
effective manner.490

       (E) If the applicant, or any agent or employee of the 491
applicant, has been found guilty of violating section 4729.51 of 492
the Revised Code, the "Federal Food, Drug, and Cosmetic Act," 52 493
Stat. 1040 (1938), 21 U.S.C.A. 301, the federal drug abuse control 494
laws, Chapter 2925., 3715., 3719., or 4729. of the Revised Code, 495
or any rule of the board, adequate safeguards are assured to 496
prevent the recurrence of the violation.497

       (F) In the case of an applicant who is a food processor or 498
retail seller of food, the applicant will maintain supervision and 499
control over the possession and custody of nitrous oxide.500

       (G) In the case of an applicant who is a retail seller of 501
oxygen in original packages labeled as required by the "Federal 502
Food, Drug, and Cosmetic Act," the applicant will maintain 503
supervision and control over the possession, custody, and retail 504
sale of the oxygen.505

       (H) If the application is made on behalf of an animal 506
shelter, at least one of the agents or employees of the animal 507
shelter is certified in compliance with section 4729.532 of the 508
Revised Code.509

       (I) In the case of an applicant who is a retail seller of 510
peritoneal dialysis solutions in original packages labeled as 511
required by the "Federal Food, Drug, and Cosmetic Act," 52 Stat. 512
1040 (1938), 21 U.S.C.A. 301, the applicant will maintain 513
supervision and control over the possession, custody, and retail 514
sale of the peritoneal dialysis solutions.515

       (J) In the case of an applicant who is a pain management 516
clinic, the applicant meets the requirements of division (A) of 517
section 4729.552 of the Revised Code.518

       Sec. 4729.552. (A) To be licensed as a terminal distributor 519
of dangerous drugs with a pain management clinic classification 520
provided under division (B) of this section, an applicant shall 521
meet all of the following requirements:522

       (1) Be in control of a facility that is owned and operated 523
solely by one or more physicians authorized under Chapter 4731. of 524
the Revised Code to practice medicine and surgery or osteopathic 525
medicine and surgery or owned and operated solely by an entity 526
described under division (B)(1)(j) or (k) of section 4729.51 of 527
the Revised Code;528

       (2) Ensure that any person employed by the facility complies 529
with the requirements for the operation of a pain management 530
clinic established by the state medical board under rules adopted 531
under section 4731.054 of the Revised Code;532

       (3) Require any person with ownership of the facility to 533
submit to a criminal records check in accordance with section 534
4776.02 of the Revised Code and send any results of the criminal 535
records check directly to the state board of pharmacy for review 536
and decision under section 4729.071 of the Revised Code;537

       (4) Require all employees of the facility to submit to a 538
criminal records check in accordance with section 4776.02 of the 539
Revised Code and ensure that no person is employed who has 540
previously been convicted of, or pleaded guilty to, any felony in 541
this state, another state, or the United States.542

       (B) If the state board of pharmacy determines that an 543
applicant meets the requirements of division (A) of this section 544
and any other applicable requirements under this chapter or 545
Chapter 3719. of the Revised Code, the board shall issue a 546
category III terminal distributor of dangerous drugs license to 547
the applicant and specify on the license that the terminal 548
distributor is classified as a pain management clinic.549

       (C) No person shall operate a terminal distributor of 550
dangerous drugs that requires pain management clinic 551
classification without complying with the requirements of this 552
section.553

       (D) The board may impose a fine of not more than five 554
thousand dollars on a terminal distributor of dangerous drugs who 555
fails to comply with division (A) or (C) of this section. A 556
separate fine may be imposed for each day of noncompliance.557

       Sec. 4729.561. If the state board of pharmacy determines that 558
there is clear and convincing evidence that the method used by a 559
wholesale distributor of dangerous drugs to distribute controlled 560
substances presents a danger of immediate and serious harm to 561
others, the board may suspend the wholesale distributor's 562
registration certificate without a hearing. The board shall follow 563
the procedure for suspension without a prior hearing in section 564
119.07 of the Revised Code. The suspension shall remain in effect, 565
unless removed by the board, until the board's final adjudication 566
order becomes effective, except that if the board does not issue 567
its final adjudication order within ninety days after the hearing, 568
the suspension shall be void on the ninety-first day after the 569
suspension.570

       Sec. 4729.571. If the state board of pharmacy determines that 571
there is clear and convincing evidence that the method used by a 572
terminal distributor to distribute controlled substances presents 573
a danger of immediate and serious harm to others, the board may 574
suspend the terminal distributor's license without a hearing. The 575
board shall follow the procedure for suspension without a prior 576
hearing in section 119.07 of the Revised Code. The suspension 577
shall remain in effect, unless removed by the board, until the 578
board's final adjudication order becomes effective, except that if 579
the board does not issue its final adjudication order within 580
ninety days after the hearing, the suspension shall be void on the 581
ninety-first day after the suspension.582

       If the terminal distributor is classified as a pain 583
management clinic, as defined in section 4731.054 of the Revised 584
Code, and the person holding the terminal distributor license also 585
holds a certificate under Chapter 4731. of the Revised Code, prior 586
to suspending the license without a hearing, the board shall 587
consult with the secretary of the state medical board or, if the 588
secretary is unavailable, another member of the board.589

       Sec. 4729.78. (A) If the state board of pharmacy establishes 590
and maintains a drug database pursuant to section 4729.75 of the 591
Revised Code, each wholesale distributor of dangerous drugs that 592
delivers drugs in this state to prescribers in this stateor 593
terminal distributors of dangerous drugs shall submit to the board 594
the following purchase information:595

       (1) Purchaser identification;596

       (2) Identification of the drug sold;597

       (3) Quantity of the drug sold;598

       (4) Date of sale;599

       (5) The wholesale distributor's license number issued by the 600
board.601

       (B) The information shall be transmitted as specified by the 602
board in rules adopted under section 4729.83 of the Revised Code.603

       (1) The information shall be submitted electronically in the 604
format specified by the board, except that the board may grant a 605
waiver allowing the distributor to submit the information in 606
another format.607

       (2) The information shall be submitted in accordance with any 608
time limits specified by the board, except that the board may 609
grant an extension if either of the following occurs:610

       (a) The distributor suffers a mechanical or electronic 611
failure, or cannot meet the deadline for other reasons beyond the 612
distributor's control.613

       (b) The board is unable to receive electronic submissions.614

       Sec. 4729.79. (A) If the state board of pharmacy establishes 615
and maintains a drug database pursuant to section 4729.75 of the 616
Revised Code, the board may provide information from the database 617
in accordance with the following:618

       (1) On receipt of a request from a designated representative 619
of a government entity responsible for the licensure, regulation, 620
or discipline of licensed health care professionals authorized621
with authority to prescribe, administer, or dispense drugs, the 622
board may provide to the representative information from the 623
database relating to the professional who is the subject of an 624
active investigation being conducted by the government entity.625

       (2) On receipt of a request from a federal officer, or a 626
state or local officer of this or any other state, whose duties 627
include enforcing laws relating to drugs, the board may provide to 628
the officer information from the database relating to the person 629
who is the subject of an active investigation of a drug abuse 630
offense, as defined in section 2925.01 of the Revised Code, being 631
conducted by the officer's employing government entity.632

       (3) Pursuant to a subpoena issued by a grand jury, the board 633
may provide to the grand jury information from the database 634
relating to the person who is the subject of an investigation 635
being conducted by the grand jury.636

       (4) On receipt of a request from a pharmacist or prescriber 637
or the prescriber's agent registered with the board, the board may 638
provide to the requestor information from the database relating to 639
a current patient of the requestorprescriber, if the requestor 640
certifies in a form specified by the board that it is for the 641
purpose of providing medical or pharmaceutical treatment to the 642
patient who is the subject of the request.643

       (5) On receipt of a request from a pharmacist, the board may 644
provide to the requestor information from the database relating to 645
a current patient of the pharmacist, if the requestor certifies in 646
a form specified by the board that it is for the purpose of the 647
practice of pharmacy involving the patient who is the subject of 648
the request.649

       (6) On receipt of a request from an individual seeking the 650
individual's own database information in accordance with the 651
procedure established in rules adopted under section 4729.83 of 652
the Revised Code, the board may provide to the individual the 653
individual's own database information.654

       (7) On receipt of a request from a requestor described in 655
division (A)(1), (2), (4), or (5) of this section who is from 656
another state's prescription monitoring program, but only if there 657
is a written agreement with that state under which the information 658
is to be used and disseminated according to the laws of this 659
state.660

       (B) The state board of pharmacy shall maintain a record of 661
each individual or entity that requests information from the 662
database pursuant to this section. In accordance with rules 663
adopted under section 4729.83 of the Revised Code, the board may 664
use the records to document and report statistics and law 665
enforcement outcomes.666

        The board may provide records of an individual's requests for 667
database information to the following:668

        (1) A designated representative of a government entity that 669
is responsible for the licensure, regulation, or discipline of670
licensed health care professionals authorizedwith authority to 671
prescribe, administer, or dispense drugs who is involved in an 672
active investigation being conducted by the government entity of 673
the individual who submitted the requests for database 674
information;675

        (2) A federal officer, or a state or local officer of this or 676
any other state, whose duties include enforcing laws relating to 677
drugs and who is involved in an active investigation being 678
conducted by the officer's employing government entity of the 679
individual who submitted the requests for database information.680

       (C) Information contained in the database and any information 681
obtained from it is not a public record. Information contained in 682
the records of requests for information from the database is not a 683
public record. Information that does not identify a person may be 684
released in summary, statistical, or aggregate form.685

       (D) Nothing in this section requires a pharmacist or 686
prescriber to obtain information about a patient from the 687
database. A pharmacist or prescriber shall not be held liable in 688
damages to any person in any civil action for injury, death, or 689
loss to person or property on the basis that the pharmacist or 690
prescriber did or did not seek or obtain information from the 691
database.692

       Sec. 4729.81. If the state board of pharmacy establishes a 693
drug database pursuant to section 4729.75 of the Revised Code, the 694
information collected for the database shall be retained in the 695
database for at least two years. TheAny information that 696
identifies a patient shall then be destroyed after it has been 697
retained for two years unless a law enforcement agency or a 698
government entity responsible for the licensure, regulation, or 699
discipline of licensed health care professionals authorized to 700
prescribe drugs has submitted a written request to the board for 701
retention of specificthe information in accordance with rules 702
adopted by the board under section 4729.83 of the Revised Code.703

       Sec. 4729.82. (A) If the state board of pharmacy establishes 704
and maintains a drug database pursuant to section 4729.75 of the 705
Revised Code, the board shall not impose any charge on a terminal 706
distributor of dangerous drugs, pharmacist, or prescriber for the 707
establishment or maintenance of the database. The board shall not 708
charge any fees for the transmission of data to the database or 709
for the receipt of information from the database, except that the 710
board may charge a fee in accordance with rules adopted under 711
section 4729.83 of the Revised Code to an individual who requests 712
the individual's own database information under section 4729.79 of 713
the Revised Code.714

       (B) The board may accept grants, gifts, or donations to 715
operate the drug database. Such grants, gifts, or donations shall 716
be deposited in the drug database fund, which is hereby created in 717
the state treasury. Money in the fund shall be used solely for the 718
operation of the drug database.719

       Sec. 4729.85. (A)(1) No person identified in divisions (A)(1) 720
to (6) or (B) of section 4729.79 of the Revised Code shall 721
disseminate any written or electronic document received from the 722
drug database to any person not authorized to receive a document 723
from the drug database.724

       (2) No person shall provide false information to the state 725
board of pharmacy with the intent to obtain information provided 726
in the drug database.727

       (3) No person shall obtain drug database information by any 728
means except as provided under divisions (A) and (B) of section 729
4729.79 of the Revised Code.730

       (B)(1) A person shall not use a document or information 731
obtained pursuant to division (A) of section 4729.79 of the 732
Revised Code as evidence in any civil, criminal, or administrative 733
proceeding.734

       (2) If a person does not comply with division (B)(1) of this 735
section, the state board of pharmacy may restrict the person from 736
obtaining further information from the drug database. The extent 737
to which the person is restricted shall be determined by the 738
board.739

       Sec. 4729.99.  (A) Whoever violates section 4729.16, division 740
(A) or (B) of section 4729.38, or section 4729.57 of the Revised 741
Code is guilty of a minor misdemeanor. Each day's violation 742
constitutes a separate offense.743

       (B) Whoever violates section 4729.27, 4729.28, or 4729.36 of 744
the Revised Code is guilty of a misdemeanor of the third degree. 745
Each day's violation constitutes a separate offense. If the 746
offender previously has been convicted of or pleaded guilty to a 747
violation of this chapter, that person is guilty of a misdemeanor 748
of the second degree.749

       (C) Whoever violates section 4729.32, 4729.33, or 4729.34 of 750
the Revised Code is guilty of a misdemeanor.751

       (D) Whoever violates division (A), (B), (D), or (E) of 752
section 4729.51 of the Revised Code is guilty of a misdemeanor of 753
the first degree.754

       (E)(1) Whoever violates section 4729.37, division (C)(2) of 755
section 4729.51, division (J) of section 4729.54, or section 756
4729.61 of the Revised Code is guilty of a felony of the fifth 757
degree. If the offender previously has been convicted of or 758
pleaded guilty to a violation of this chapter or a violation of 759
Chapter 2925. or 3719. of the Revised Code, that person is guilty 760
of a felony of the fourth degree.761

       (2) If an offender is convicted of or pleads guilty to a 762
violation of section 4729.37, division (C) of section 4729.51, 763
division (J) of section 4729.54, or section 4729.61 of the Revised 764
Code, if the violation involves the sale, offer to sell, or 765
possession of a schedule I or II controlled substance, with the 766
exception of marihuana, and if the court imposing sentence upon 767
the offender finds that the offender as a result of the violation 768
is a major drug offender, as defined in section 2929.01 of the 769
Revised Code, and is guilty of a specification of the type 770
described in section 2941.1410 of the Revised Code, the court, in 771
lieu of the prison term authorized or required by division (E)(1) 772
of this section and sections 2929.13 and 2929.14 of the Revised 773
Code and in addition to any other sanction imposed for the offense 774
under sections 2929.11 to 2929.18 of the Revised Code, shall 775
impose upon the offender, in accordance with division (D)(3)(a) of 776
section 2929.14 of the Revised Code, the mandatory prison term 777
specified in that division and may impose an additional prison 778
term under division (D)(3)(b) of that section.779

       (3) Notwithstanding any contrary provision of section 3719.21 780
of the Revised Code, the clerk of court shall pay any fine imposed 781
for a violation of section 4729.37, division (C) of section 782
4729.51, division (J) of section 4729.54, or section 4729.61 of 783
the Revised Code pursuant to division (A) of section 2929.18 of 784
the Revised Code in accordance with and subject to the 785
requirements of division (F) of section 2925.03 of the Revised 786
Code. The agency that receives the fine shall use the fine as 787
specified in division (F) of section 2925.03 of the Revised Code.788

       (F) Whoever violates section 4729.531 of the Revised Code or 789
any rule adopted thereunder or section 4729.532 of the Revised 790
Code is guilty of a misdemeanor of the first degree.791

       (G) Whoever violates division (C)(1) of section 4729.51 of 792
the Revised Code is guilty of a felony of the fourth degree. If 793
the offender has previously been convicted of or pleaded guilty to 794
a violation of this chapter, or of a violation of Chapter 2925. or 795
3719. of the Revised Code, that person is guilty of a felony of 796
the third degree.797

       (H) Whoever violates division (C)(3) of section 4729.51 of 798
the Revised Code is guilty of a misdemeanor of the first degree. 799
If the offender has previously been convicted of or pleaded guilty 800
to a violation of this chapter, or of a violation of Chapter 2925. 801
or 3719. of the Revised Code, that person is guilty of a felony of 802
the fifth degree.803

       (I)(1) Whoever violates division (B) of section 4729.42 of 804
the Revised Code is guilty of unauthorized pharmacy-related drug 805
conduct. Except as otherwise provided in this section, 806
unauthorized pharmacy-related drug conduct is a misdemeanor of the 807
second degree. If the offender previously has been convicted of or 808
pleaded guilty to a violation of division (B), (C), (D), or (E) of 809
that section, unauthorized pharmacy-related drug conduct is a 810
misdemeanor of the first degree on a second offense and a felony 811
of the fifth degree on a third or subsequent offense.812

       (2) Whoever violates division (C) or (D) of section 4729.42 813
of the Revised Code is guilty of permitting unauthorized 814
pharmacy-related drug conduct. Except as otherwise provided in 815
this section, permitting unauthorized pharmacy-related drug 816
conduct is a misdemeanor of the second degree. If the offender 817
previously has been convicted of or pleaded guilty to a violation 818
of division (B), (C), (D), or (E) of that section, permitting 819
unauthorized pharmacy-related drug conduct is a misdemeanor of the 820
first degree on a second offense and a felony of the fifth degree 821
on a third or subsequent offense.822

       (3) Whoever violates division (E) of section 4729.42 of the 823
Revised Code is guilty of the offense of falsification under 824
section 2921.13 of the Revised Code. In addition to any other 825
sanction imposed for the violation, the offender is forever 826
disqualified from engaging in any activity specified in division 827
(B)(1), (2), or (3) of section 4729.42 of the Revised Code and 828
from performing any function as a health care professional or 829
health care worker. As used in this division, "health care 830
professional" and "health care worker" have the same meanings as 831
in section 2305.234 of the Revised Code.832

       (4) Notwithstanding any contrary provision of section 3719.21 833
of the Revised Code or any other provision of law that governs the 834
distribution of fines, the clerk of the court shall pay any fine 835
imposed pursuant to division (I)(1), (2), or (3) of this section 836
to the state board of pharmacy if the board has adopted a written 837
internal control policy under division (F)(2) of section 2925.03 838
of the Revised Code that addresses fine moneys that it receives 839
under Chapter 2925. of the Revised Code and if the policy also 840
addresses fine moneys paid under this division. The state board of 841
pharmacy shall use the fines so paid in accordance with the 842
written internal control policy to subsidize the board's law 843
enforcement efforts that pertain to drug offenses.844

       (J)(1) Whoever violates division (A)(1) of section 4729.85 of 845
the Revised Code is guilty of a misdemeanor of the third degree. 846
If the offender has previously been convicted of or pleaded guilty 847
to a violation of section 4729.85 of the Revised Code, that person 848
is guilty of a misdemeanor of the first degree.849

       (2) Whoever violates division (A)(2) of section 4729.85 of 850
the Revised Code is guilty of a misdemeanor of the first degree. 851
If the offender has previously been convicted of or pleaded guilty 852
to a violation of section 4729.85 of the Revised Code, that person 853
is guilty of a felony of the fifth degree.854

       (3) Whoever violates division (A)(3) of section 4729.85 of 855
the Revised Code is guilty of a felony of the fifth degree. If the 856
offender has previously been convicted of or pleaded guilty to a 857
violation of section 4729.85 of the Revised Code, that person is 858
guilty of a felony of the fourth degree.859

       (K) A person who violates division (C) of section 4729.552 of 860
the Revised Code is guilty of a misdemeanor of the first degree. 861
If the person previously has been convicted of or pleaded guilty 862
to a violation of section 4729.552 of the Revised Code, that 863
person is guilty of a felony of the fifth degree.864

       Sec. 4731.052.  (A) As used in this section:865

       (1) "Dangerous drug" has the same meaning as in section 866
4729.01 of the Revised Code.867

       (2) "Intractable pain" means a state of pain that is 868
determined, after reasonable medical efforts have been made to 869
relieve the pain or cure its cause, to have a cause for which no 870
treatment or cure is possible or for which none has been found871
Chronic pain" means pain that has persisted after reasonable 872
medical efforts have been made to relieve the pain or cure its 873
cause and that has continued, either continuously or episodically, 874
for longer than three continuous months. "Chronic pain" does not 875
include pain associated with a terminal condition or with a 876
progressive disease that, in the normal course of progression, may 877
reasonably be expected to result in a terminal condition.878

       (3) "Physician" means an individual authorized under this 879
chapter to practice medicine and surgery or osteopathic medicine 880
and surgery.881

       (B) The state medical board shall adopt rules in accordance 882
with Chapter 119. of the Revised Code that establish standards and 883
procedures to be followed by physicians in the diagnosis and 884
treatment of intractablechronic pain, including standards for 885
managing intractablechronic pain by prescribing, personally 886
furnishing, or administering dangerous drugs in amounts or 887
combinations that may not be appropriate when treating other 888
medical conditions. In developing the rules, the board shall 889
consult with and permit review by physicians who are experienced 890
in the diagnosis and treatment of intractablechronic pain.891

       (C) When a physician diagnoses an individual as having 892
intractablechronic pain, the physician may treat the pain by 893
managing it with dangerous drugs in amounts or combinations that 894
may not be appropriate when treating other medical conditions. The 895
physician's diagnosis shall be made after having the individual 896
evaluated by one or more other physicians who specialize in the 897
treatment of the area, system, or organ of the body perceived as 898
the source of the pain. The physician's diagnosis and treatment 899
decisions shall be made according to accepted and prevailing 900
standards for medical care. The physician shall maintain a record 901
of all of the following:902

       (1) Medical history and physical examination of the 903
individual;904

       (2) The diagnosis of intractablechronic pain, including 905
signs, symptoms, and causes;906

       (3) The plan of treatment proposed, the patient's response to 907
treatment, and any modification to the plan of treatment;908

       (4) The dates on which dangerous drugs were prescribed, 909
furnished, or administered, the name and address of the individual 910
to or for whom the dangerous drugs were prescribed, dispensed, or 911
administered, and the amounts and dosage forms for the dangerous 912
drugs prescribed, furnished, or administered;913

       (5) A copy of the report made by the physician or the 914
physician to whom referral for evaluation was made under this 915
division.916

       (D) A physician who treats intractablechronic pain by 917
managing it with dangerous drugs is not subject to disciplinary 918
action by the board under section 4731.22 of the Revised Code 919
solely because the physician treated the intractablechronic pain 920
with dangerous drugs. The physician is subject to disciplinary 921
action only if the dangerous drugs are not prescribed, furnished, 922
or administered in accordance with this section and the rules 923
adopted under it.924

       Sec. 4731.054. (A) As used in this section:925

       (1) "Chronic pain" has the same meaning as in section 926
4731.052 of the Revised Code.927

       (2) "Controlled substance" has the same meaning as in section 928
3719.01 of the Revised Code.929

       (3) "Narcotic drug" has the same meaning as in section 930
3719.01 of the Revised Code.931

       (4)(a) "Pain management clinic" means a facility to which 932
both of the following apply:933

       (i) The facility, as the primary component of its practice, 934
provides treatment for pain;935

       (ii) The majority of patients at the facility are provided 936
treatment for chronic pain with the use of controlled substances 937
that are narcotic drugs or with the use of tramadol.938

       (b) "Pain management clinic" does not include any of the 939
following:940

       (i) A hospital registered with the department of health under 941
section 3701.07 of the Revised Code or a facility owned by such a 942
hospital;943

       (ii) A medical or dental school that is part of or affiliated 944
with a state institution of higher education or an institution 945
that holds a certificate of authorization issued by the Ohio board 946
of regents under section 1713.02 of the Revised Code or a facility 947
affiliated with such a medical or dental school;948

       (iii) A hospice program licensed under Chapter 3712. of the 949
Revised Code.950

       (5) "Physician" means an individual authorized under this 951
chapter to practice medicine and surgery or osteopathic medicine 952
and surgery.953

       (B) The state medical board shall adopt rules in accordance 954
with Chapter 119. of the Revised Code establishing standards for 955
the operation of a pain management clinic by a physician. The 956
rules shall include standards to be followed by physicians who 957
provide care at pain management clinics.958

       (C) The board may impose a penalty of not more than twenty 959
thousand dollars on any physician who fails to comply with rules 960
adopted under division (B) of this section. The penalty imposed 961
under this division may be in addition to or in lieu of any other 962
action that may be taken by the board under section 4731.22 of the 963
Revised Code. The board shall deposit any amounts received under 964
this division in accordance with section 4731.24 of the Revised 965
Code.966

       Sec. 4731.055. (A) As used in this section:967

       (1) "Physician" means an individual authorized under this 968
chapter to practice medicine and surgery or osteopathic medicine 969
and surgery.970

       (2) "Drug database" means the database established by the 971
state board of pharmacy pursuant to section 4729.75 of the Revised 972
Code.973

       (B) The state medical board shall adopt rules in accordance 974
with Chapter 119. of the Revised Code that establish standards and 975
procedures to be followed by physicians regarding the review of 976
patient information available through the drug database.977

       (C) The rules adopted under this section shall not apply if 978
the state board of pharmacy does not establish the drug database 979
or discontinues operation of the drug database.980

       Sec. 4731.22.  (A) The state medical board, by an affirmative 981
vote of not fewer than six of its members, may revoke or may 982
refuse to grant a certificate to a person found by the board to 983
have committed fraud during the administration of the examination 984
for a certificate to practice or to have committed fraud, 985
misrepresentation, or deception in applying for or securing any 986
certificate to practice or certificate of registration issued by 987
the board.988

       (B) The board, by an affirmative vote of not fewer than six 989
members, shall, to the extent permitted by law, limit, revoke, or 990
suspend an individual's certificate to practice, refuse to 991
register an individual, refuse to reinstate a certificate, or 992
reprimand or place on probation the holder of a certificate for 993
one or more of the following reasons:994

       (1) Permitting one's name or one's certificate to practice or 995
certificate of registration to be used by a person, group, or 996
corporation when the individual concerned is not actually 997
directing the treatment given;998

       (2) Failure to maintain minimal standards applicable to the 999
selection or administration of drugs, or failure to employ 1000
acceptable scientific methods in the selection of drugs or other 1001
modalities for treatment of disease;1002

       (3) Selling, giving away, personally furnishing, prescribing, 1003
or administering drugs for other than legal and legitimate 1004
therapeutic purposes or a plea of guilty to, a judicial finding of 1005
guilt of, or a judicial finding of eligibility for intervention in 1006
lieu of conviction of, a violation of any federal or state law 1007
regulating the possession, distribution, or use of any drug;1008

       (4) Willfully betraying a professional confidence.1009

       For purposes of this division, "willfully betraying a 1010
professional confidence" does not include providing any 1011
information, documents, or reports to a child fatality review 1012
board under sections 307.621 to 307.629 of the Revised Code and 1013
does not include the making of a report of an employee's use of a 1014
drug of abuse, or a report of a condition of an employee other 1015
than one involving the use of a drug of abuse, to the employer of 1016
the employee as described in division (B) of section 2305.33 of 1017
the Revised Code. Nothing in this division affects the immunity 1018
from civil liability conferred by that section upon a physician 1019
who makes either type of report in accordance with division (B) of 1020
that section. As used in this division, "employee," "employer," 1021
and "physician" have the same meanings as in section 2305.33 of 1022
the Revised Code.1023

       (5) Making a false, fraudulent, deceptive, or misleading 1024
statement in the solicitation of or advertising for patients; in 1025
relation to the practice of medicine and surgery, osteopathic 1026
medicine and surgery, podiatric medicine and surgery, or a limited 1027
branch of medicine; or in securing or attempting to secure any 1028
certificate to practice or certificate of registration issued by 1029
the board.1030

       As used in this division, "false, fraudulent, deceptive, or 1031
misleading statement" means a statement that includes a 1032
misrepresentation of fact, is likely to mislead or deceive because 1033
of a failure to disclose material facts, is intended or is likely 1034
to create false or unjustified expectations of favorable results, 1035
or includes representations or implications that in reasonable 1036
probability will cause an ordinarily prudent person to 1037
misunderstand or be deceived.1038

       (6) A departure from, or the failure to conform to, minimal 1039
standards of care of similar practitioners under the same or 1040
similar circumstances, whether or not actual injury to a patient 1041
is established;1042

       (7) Representing, with the purpose of obtaining compensation 1043
or other advantage as personal gain or for any other person, that 1044
an incurable disease or injury, or other incurable condition, can 1045
be permanently cured;1046

       (8) The obtaining of, or attempting to obtain, money or 1047
anything of value by fraudulent misrepresentations in the course 1048
of practice;1049

       (9) A plea of guilty to, a judicial finding of guilt of, or a 1050
judicial finding of eligibility for intervention in lieu of 1051
conviction for, a felony;1052

       (10) Commission of an act that constitutes a felony in this 1053
state, regardless of the jurisdiction in which the act was 1054
committed;1055

       (11) A plea of guilty to, a judicial finding of guilt of, or 1056
a judicial finding of eligibility for intervention in lieu of 1057
conviction for, a misdemeanor committed in the course of practice;1058

       (12) Commission of an act in the course of practice that 1059
constitutes a misdemeanor in this state, regardless of the 1060
jurisdiction in which the act was committed;1061

       (13) A plea of guilty to, a judicial finding of guilt of, or 1062
a judicial finding of eligibility for intervention in lieu of 1063
conviction for, a misdemeanor involving moral turpitude;1064

       (14) Commission of an act involving moral turpitude that 1065
constitutes a misdemeanor in this state, regardless of the 1066
jurisdiction in which the act was committed;1067

       (15) Violation of the conditions of limitation placed by the 1068
board upon a certificate to practice;1069

       (16) Failure to pay license renewal fees specified in this 1070
chapter;1071

       (17) Except as authorized in section 4731.31 of the Revised 1072
Code, engaging in the division of fees for referral of patients, 1073
or the receiving of a thing of value in return for a specific 1074
referral of a patient to utilize a particular service or business;1075

       (18) Subject to section 4731.226 of the Revised Code, 1076
violation of any provision of a code of ethics of the American 1077
medical association, the American osteopathic association, the 1078
American podiatric medical association, or any other national 1079
professional organizations that the board specifies by rule. The 1080
state medical board shall obtain and keep on file current copies 1081
of the codes of ethics of the various national professional 1082
organizations. The individual whose certificate is being suspended 1083
or revoked shall not be found to have violated any provision of a 1084
code of ethics of an organization not appropriate to the 1085
individual's profession.1086

       For purposes of this division, a "provision of a code of 1087
ethics of a national professional organization" does not include 1088
any provision that would preclude the making of a report by a 1089
physician of an employee's use of a drug of abuse, or of a 1090
condition of an employee other than one involving the use of a 1091
drug of abuse, to the employer of the employee as described in 1092
division (B) of section 2305.33 of the Revised Code. Nothing in 1093
this division affects the immunity from civil liability conferred 1094
by that section upon a physician who makes either type of report 1095
in accordance with division (B) of that section. As used in this 1096
division, "employee," "employer," and "physician" have the same 1097
meanings as in section 2305.33 of the Revised Code.1098

       (19) Inability to practice according to acceptable and 1099
prevailing standards of care by reason of mental illness or 1100
physical illness, including, but not limited to, physical 1101
deterioration that adversely affects cognitive, motor, or 1102
perceptive skills.1103

       In enforcing this division, the board, upon a showing of a 1104
possible violation, may compel any individual authorized to 1105
practice by this chapter or who has submitted an application 1106
pursuant to this chapter to submit to a mental examination, 1107
physical examination, including an HIV test, or both a mental and 1108
a physical examination. The expense of the examination is the 1109
responsibility of the individual compelled to be examined. Failure 1110
to submit to a mental or physical examination or consent to an HIV 1111
test ordered by the board constitutes an admission of the 1112
allegations against the individual unless the failure is due to 1113
circumstances beyond the individual's control, and a default and 1114
final order may be entered without the taking of testimony or 1115
presentation of evidence. If the board finds an individual unable 1116
to practice because of the reasons set forth in this division, the 1117
board shall require the individual to submit to care, counseling, 1118
or treatment by physicians approved or designated by the board, as 1119
a condition for initial, continued, reinstated, or renewed 1120
authority to practice. An individual affected under this division 1121
shall be afforded an opportunity to demonstrate to the board the 1122
ability to resume practice in compliance with acceptable and 1123
prevailing standards under the provisions of the individual's 1124
certificate. For the purpose of this division, any individual who 1125
applies for or receives a certificate to practice under this 1126
chapter accepts the privilege of practicing in this state and, by 1127
so doing, shall be deemed to have given consent to submit to a 1128
mental or physical examination when directed to do so in writing 1129
by the board, and to have waived all objections to the 1130
admissibility of testimony or examination reports that constitute 1131
a privileged communication.1132

       (20) Except when civil penalties are imposed under section 1133
4731.225 or 4731.281 of the Revised Code, and subject to section 1134
4731.226 of the Revised Code, violating or attempting to violate, 1135
directly or indirectly, or assisting in or abetting the violation 1136
of, or conspiring to violate, any provisions of this chapter or 1137
any rule promulgated by the board.1138

       This division does not apply to a violation or attempted 1139
violation of, assisting in or abetting the violation of, or a 1140
conspiracy to violate, any provision of this chapter or any rule 1141
adopted by the board that would preclude the making of a report by 1142
a physician of an employee's use of a drug of abuse, or of a 1143
condition of an employee other than one involving the use of a 1144
drug of abuse, to the employer of the employee as described in 1145
division (B) of section 2305.33 of the Revised Code. Nothing in 1146
this division affects the immunity from civil liability conferred 1147
by that section upon a physician who makes either type of report 1148
in accordance with division (B) of that section. As used in this 1149
division, "employee," "employer," and "physician" have the same 1150
meanings as in section 2305.33 of the Revised Code.1151

       (21) The violation of section 3701.79 of the Revised Code or 1152
of any abortion rule adopted by the public health council pursuant 1153
to section 3701.341 of the Revised Code;1154

       (22) Any of the following actions taken by the agency 1155
responsible for regulating the practice of medicine and surgery, 1156
osteopathic medicine and surgery, podiatric medicine and surgery, 1157
or the limited branches of medicine in another jurisdiction, for 1158
any reason other than the nonpayment of fees: the limitation, 1159
revocation, or suspension of an individual's license to practice; 1160
acceptance of an individual's license surrender; denial of a 1161
license; refusal to renew or reinstate a license; imposition of 1162
probation; or issuance of an order of censure or other reprimand;1163

       (23) The violation of section 2919.12 of the Revised Code or 1164
the performance or inducement of an abortion upon a pregnant woman 1165
with actual knowledge that the conditions specified in division 1166
(B) of section 2317.56 of the Revised Code have not been satisfied 1167
or with a heedless indifference as to whether those conditions 1168
have been satisfied, unless an affirmative defense as specified in 1169
division (H)(2) of that section would apply in a civil action 1170
authorized by division (H)(1) of that section;1171

       (24) The revocation, suspension, restriction, reduction, or 1172
termination of clinical privileges by the United States department 1173
of defense or department of veterans affairs or the termination or 1174
suspension of a certificate of registration to prescribe drugs by 1175
the drug enforcement administration of the United States 1176
department of justice;1177

       (25) Termination or suspension from participation in the 1178
medicare or medicaid programs by the department of health and 1179
human services or other responsible agency for any act or acts 1180
that also would constitute a violation of division (B)(2), (3), 1181
(6), (8), or (19) of this section;1182

       (26) Impairment of ability to practice according to 1183
acceptable and prevailing standards of care because of habitual or 1184
excessive use or abuse of drugs, alcohol, or other substances that 1185
impair ability to practice.1186

       For the purposes of this division, any individual authorized 1187
to practice by this chapter accepts the privilege of practicing in 1188
this state subject to supervision by the board. By filing an 1189
application for or holding a certificate to practice under this 1190
chapter, an individual shall be deemed to have given consent to 1191
submit to a mental or physical examination when ordered to do so 1192
by the board in writing, and to have waived all objections to the 1193
admissibility of testimony or examination reports that constitute 1194
privileged communications.1195

       If it has reason to believe that any individual authorized to 1196
practice by this chapter or any applicant for certification to 1197
practice suffers such impairment, the board may compel the 1198
individual to submit to a mental or physical examination, or both. 1199
The expense of the examination is the responsibility of the 1200
individual compelled to be examined. Any mental or physical 1201
examination required under this division shall be undertaken by a 1202
treatment provider or physician who is qualified to conduct the 1203
examination and who is chosen by the board.1204

       Failure to submit to a mental or physical examination ordered 1205
by the board constitutes an admission of the allegations against 1206
the individual unless the failure is due to circumstances beyond 1207
the individual's control, and a default and final order may be 1208
entered without the taking of testimony or presentation of 1209
evidence. If the board determines that the individual's ability to 1210
practice is impaired, the board shall suspend the individual's 1211
certificate or deny the individual's application and shall require 1212
the individual, as a condition for initial, continued, reinstated, 1213
or renewed certification to practice, to submit to treatment.1214

       Before being eligible to apply for reinstatement of a 1215
certificate suspended under this division, the impaired 1216
practitioner shall demonstrate to the board the ability to resume 1217
practice in compliance with acceptable and prevailing standards of 1218
care under the provisions of the practitioner's certificate. The 1219
demonstration shall include, but shall not be limited to, the 1220
following:1221

       (a) Certification from a treatment provider approved under 1222
section 4731.25 of the Revised Code that the individual has 1223
successfully completed any required inpatient treatment;1224

       (b) Evidence of continuing full compliance with an aftercare 1225
contract or consent agreement;1226

       (c) Two written reports indicating that the individual's 1227
ability to practice has been assessed and that the individual has 1228
been found capable of practicing according to acceptable and 1229
prevailing standards of care. The reports shall be made by 1230
individuals or providers approved by the board for making the 1231
assessments and shall describe the basis for their determination.1232

       The board may reinstate a certificate suspended under this 1233
division after that demonstration and after the individual has 1234
entered into a written consent agreement.1235

       When the impaired practitioner resumes practice, the board 1236
shall require continued monitoring of the individual. The 1237
monitoring shall include, but not be limited to, compliance with 1238
the written consent agreement entered into before reinstatement or 1239
with conditions imposed by board order after a hearing, and, upon 1240
termination of the consent agreement, submission to the board for 1241
at least two years of annual written progress reports made under 1242
penalty of perjury stating whether the individual has maintained 1243
sobriety.1244

       (27) A second or subsequent violation of section 4731.66 or 1245
4731.69 of the Revised Code;1246

       (28) Except as provided in division (N) of this section:1247

       (a) Waiving the payment of all or any part of a deductible or 1248
copayment that a patient, pursuant to a health insurance or health 1249
care policy, contract, or plan that covers the individual's 1250
services, otherwise would be required to pay if the waiver is used 1251
as an enticement to a patient or group of patients to receive 1252
health care services from that individual;1253

       (b) Advertising that the individual will waive the payment of 1254
all or any part of a deductible or copayment that a patient, 1255
pursuant to a health insurance or health care policy, contract, or 1256
plan that covers the individual's services, otherwise would be 1257
required to pay.1258

       (29) Failure to use universal blood and body fluid 1259
precautions established by rules adopted under section 4731.051 of 1260
the Revised Code;1261

       (30) Failure to provide notice to, and receive acknowledgment 1262
of the notice from, a patient when required by section 4731.143 of 1263
the Revised Code prior to providing nonemergency professional 1264
services, or failure to maintain that notice in the patient's 1265
file;1266

       (31) Failure of a physician supervising a physician assistant 1267
to maintain supervision in accordance with the requirements of 1268
Chapter 4730. of the Revised Code and the rules adopted under that 1269
chapter;1270

       (32) Failure of a physician or podiatrist to enter into a 1271
standard care arrangement with a clinical nurse specialist, 1272
certified nurse-midwife, or certified nurse practitioner with whom 1273
the physician or podiatrist is in collaboration pursuant to 1274
section 4731.27 of the Revised Code or failure to fulfill the 1275
responsibilities of collaboration after entering into a standard 1276
care arrangement;1277

       (33) Failure to comply with the terms of a consult agreement 1278
entered into with a pharmacist pursuant to section 4729.39 of the 1279
Revised Code;1280

       (34) Failure to cooperate in an investigation conducted by 1281
the board under division (F) of this section, including failure to 1282
comply with a subpoena or order issued by the board or failure to 1283
answer truthfully a question presented by the board at a 1284
deposition or in written interrogatories, except that failure to 1285
cooperate with an investigation shall not constitute grounds for 1286
discipline under this section if a court of competent jurisdiction 1287
has issued an order that either quashes a subpoena or permits the 1288
individual to withhold the testimony or evidence in issue;1289

       (35) Failure to supervise an acupuncturist in accordance with 1290
Chapter 4762. of the Revised Code and the board's rules for 1291
supervision of an acupuncturist;1292

       (36) Failure to supervise an anesthesiologist assistant in 1293
accordance with Chapter 4760. of the Revised Code and the board's 1294
rules for supervision of an anesthesiologist assistant;1295

       (37) Assisting suicide as defined in section 3795.01 of the 1296
Revised Code;1297

       (38) Failure to comply with the requirements of section 1298
2317.561 of the Revised Code;1299

       (39) Failure to supervise a radiologist assistant in 1300
accordance with Chapter 4774. of the Revised Code and the board's 1301
rules for supervision of radiologist assistants;1302

       (40) Performing or inducing an abortion at an office or 1303
facility with knowledge that the office or facility fails to post 1304
the notice required under section 3701.791 of the Revised Code;1305

       (41) Holding a terminal distributor of dangerous drugs 1306
license with a pain management clinic classification under section 1307
4729.552 of the Revised Code if any person employed by the clinic 1308
has violated Chapter 2925. of the Revised Code or is subject to 1309
disciplinary action under this section or section 4723.28 or 1310
4730.25 of the Revised Code.1311

       (C) Disciplinary actions taken by the board under divisions 1312
(A) and (B) of this section shall be taken pursuant to an 1313
adjudication under Chapter 119. of the Revised Code, except that 1314
in lieu of an adjudication, the board may enter into a consent 1315
agreement with an individual to resolve an allegation of a 1316
violation of this chapter or any rule adopted under it. A consent 1317
agreement, when ratified by an affirmative vote of not fewer than 1318
six members of the board, shall constitute the findings and order 1319
of the board with respect to the matter addressed in the 1320
agreement. If the board refuses to ratify a consent agreement, the 1321
admissions and findings contained in the consent agreement shall 1322
be of no force or effect.1323

       If the board takes disciplinary action against an individual 1324
under division (B) of this section for a second or subsequent plea 1325
of guilty to, or judicial finding of guilt of, a violation of 1326
section 2919.123 of the Revised Code, the disciplinary action 1327
shall consist of a suspension of the individual's certificate to 1328
practice for a period of at least one year or, if determined 1329
appropriate by the board, a more serious sanction involving the 1330
individual's certificate to practice. Any consent agreement 1331
entered into under this division with an individual that pertains 1332
to a second or subsequent plea of guilty to, or judicial finding 1333
of guilt of, a violation of that section shall provide for a 1334
suspension of the individual's certificate to practice for a 1335
period of at least one year or, if determined appropriate by the 1336
board, a more serious sanction involving the individual's 1337
certificate to practice.1338

       (D) For purposes of divisions (B)(10), (12), and (14) of this 1339
section, the commission of the act may be established by a finding 1340
by the board, pursuant to an adjudication under Chapter 119. of 1341
the Revised Code, that the individual committed the act. The board 1342
does not have jurisdiction under those divisions if the trial 1343
court renders a final judgment in the individual's favor and that 1344
judgment is based upon an adjudication on the merits. The board 1345
has jurisdiction under those divisions if the trial court issues 1346
an order of dismissal upon technical or procedural grounds.1347

       (E) The sealing of conviction records by any court shall have 1348
no effect upon a prior board order entered under this section or 1349
upon the board's jurisdiction to take action under this section 1350
if, based upon a plea of guilty, a judicial finding of guilt, or a 1351
judicial finding of eligibility for intervention in lieu of 1352
conviction, the board issued a notice of opportunity for a hearing 1353
prior to the court's order to seal the records. The board shall 1354
not be required to seal, destroy, redact, or otherwise modify its 1355
records to reflect the court's sealing of conviction records.1356

       (F)(1) The board shall investigate evidence that appears to 1357
show that a person has violated any provision of this chapter or 1358
any rule adopted under it. Any person may report to the board in a 1359
signed writing any information that the person may have that 1360
appears to show a violation of any provision of this chapter or 1361
any rule adopted under it. In the absence of bad faith, any person 1362
who reports information of that nature or who testifies before the 1363
board in any adjudication conducted under Chapter 119. of the 1364
Revised Code shall not be liable in damages in a civil action as a 1365
result of the report or testimony. Each complaint or allegation of 1366
a violation received by the board shall be assigned a case number 1367
and shall be recorded by the board.1368

       (2) Investigations of alleged violations of this chapter or 1369
any rule adopted under it shall be supervised by the supervising 1370
member elected by the board in accordance with section 4731.02 of 1371
the Revised Code and by the secretary as provided in section 1372
4731.39 of the Revised Code. The president may designate another 1373
member of the board to supervise the investigation in place of the 1374
supervising member. No member of the board who supervises the 1375
investigation of a case shall participate in further adjudication 1376
of the case.1377

       (3) In investigating a possible violation of this chapter or 1378
any rule adopted under this chapter, the board may administer 1379
oaths, order the taking of depositions, issue subpoenas, and 1380
compel the attendance of witnesses and production of books, 1381
accounts, papers, records, documents, and testimony, except that a 1382
subpoena for patient record information shall not be issued 1383
without consultation with the attorney general's office and 1384
approval of the secretary and supervising member of the board. 1385
Before issuance of a subpoena for patient record information, the 1386
secretary and supervising member shall determine whether there is 1387
probable cause to believe that the complaint filed alleges a 1388
violation of this chapter or any rule adopted under it and that 1389
the records sought are relevant to the alleged violation and 1390
material to the investigation. The subpoena may apply only to 1391
records that cover a reasonable period of time surrounding the 1392
alleged violation.1393

       On failure to comply with any subpoena issued by the board 1394
and after reasonable notice to the person being subpoenaed, the 1395
board may move for an order compelling the production of persons 1396
or records pursuant to the Rules of Civil Procedure.1397

       A subpoena issued by the board may be served by a sheriff, 1398
the sheriff's deputy, or a board employee designated by the board. 1399
Service of a subpoena issued by the board may be made by 1400
delivering a copy of the subpoena to the person named therein, 1401
reading it to the person, or leaving it at the person's usual 1402
place of residence. When the person being served is a person whose 1403
practice is authorized by this chapter, service of the subpoena 1404
may be made by certified mail, restricted delivery, return receipt 1405
requested, and the subpoena shall be deemed served on the date 1406
delivery is made or the date the person refuses to accept 1407
delivery.1408

       A sheriff's deputy who serves a subpoena shall receive the 1409
same fees as a sheriff. Each witness who appears before the board 1410
in obedience to a subpoena shall receive the fees and mileage 1411
provided for under section 119.094 of the Revised Code.1412

       (4) All hearings and investigations of the board shall be 1413
considered civil actions for the purposes of section 2305.252 of 1414
the Revised Code.1415

       (5) Information received by the board pursuant to an 1416
investigation is confidential and not subject to discovery in any 1417
civil action.1418

       The board shall conduct all investigations and proceedings in 1419
a manner that protects the confidentiality of patients and persons 1420
who file complaints with the board. The board shall not make 1421
public the names or any other identifying information about 1422
patients or complainants unless proper consent is given or, in the 1423
case of a patient, a waiver of the patient privilege exists under 1424
division (B) of section 2317.02 of the Revised Code, except that 1425
consent or a waiver of that nature is not required if the board 1426
possesses reliable and substantial evidence that no bona fide 1427
physician-patient relationship exists.1428

       The board may share any information it receives pursuant to 1429
an investigation, including patient records and patient record 1430
information, with law enforcement agencies, other licensing 1431
boards, and other governmental agencies that are prosecuting, 1432
adjudicating, or investigating alleged violations of statutes or 1433
administrative rules. An agency or board that receives the 1434
information shall comply with the same requirements regarding 1435
confidentiality as those with which the state medical board must 1436
comply, notwithstanding any conflicting provision of the Revised 1437
Code or procedure of the agency or board that applies when it is 1438
dealing with other information in its possession. In a judicial 1439
proceeding, the information may be admitted into evidence only in 1440
accordance with the Rules of Evidence, but the court shall require 1441
that appropriate measures are taken to ensure that confidentiality 1442
is maintained with respect to any part of the information that 1443
contains names or other identifying information about patients or 1444
complainants whose confidentiality was protected by the state 1445
medical board when the information was in the board's possession. 1446
Measures to ensure confidentiality that may be taken by the court 1447
include sealing its records or deleting specific information from 1448
its records.1449

       (6) On a quarterly basis, the board shall prepare a report 1450
that documents the disposition of all cases during the preceding 1451
three months. The report shall contain the following information 1452
for each case with which the board has completed its activities:1453

       (a) The case number assigned to the complaint or alleged 1454
violation;1455

       (b) The type of certificate to practice, if any, held by the 1456
individual against whom the complaint is directed;1457

       (c) A description of the allegations contained in the 1458
complaint;1459

       (d) The disposition of the case.1460

       The report shall state how many cases are still pending and 1461
shall be prepared in a manner that protects the identity of each 1462
person involved in each case. The report shall be a public record 1463
under section 149.43 of the Revised Code.1464

       (G) If the secretary and supervising member determine that 1465
there is clear and convincing evidence that an individual has 1466
violated division (B) of this section and that the individual's 1467
continued practice presents a danger of immediate and serious harm 1468
to the public, they may recommend that the board suspend the 1469
individual's certificate to practice without a prior hearing. 1470
Written allegations shall be prepared for consideration by the 1471
board.1472

       The board, upon review of those allegations and by an 1473
affirmative vote of not fewer than six of its members, excluding 1474
the secretary and supervising member, may suspend a certificate 1475
without a prior hearing. A telephone conference call may be 1476
utilized for reviewing the allegations and taking the vote on the 1477
summary suspension.1478

       The board shall issue a written order of suspension by 1479
certified mail or in person in accordance with section 119.07 of 1480
the Revised Code. The order shall not be subject to suspension by 1481
the court during pendency of any appeal filed under section 119.12 1482
of the Revised Code. If the individual subject to the summary 1483
suspension requests an adjudicatory hearing by the board, the date 1484
set for the hearing shall be within fifteen days, but not earlier 1485
than seven days, after the individual requests the hearing, unless 1486
otherwise agreed to by both the board and the individual.1487

       Any summary suspension imposed under this division shall 1488
remain in effect, unless reversed on appeal, until a final 1489
adjudicative order issued by the board pursuant to this section 1490
and Chapter 119. of the Revised Code becomes effective. The board 1491
shall issue its final adjudicative order within seventy-five days 1492
after completion of its hearing. A failure to issue the order 1493
within seventy-five days shall result in dissolution of the 1494
summary suspension order but shall not invalidate any subsequent, 1495
final adjudicative order.1496

       (H) If the board takes action under division (B)(9), (11), or 1497
(13) of this section and the judicial finding of guilt, guilty 1498
plea, or judicial finding of eligibility for intervention in lieu 1499
of conviction is overturned on appeal, upon exhaustion of the 1500
criminal appeal, a petition for reconsideration of the order may 1501
be filed with the board along with appropriate court documents. 1502
Upon receipt of a petition of that nature and supporting court 1503
documents, the board shall reinstate the individual's certificate 1504
to practice. The board may then hold an adjudication under Chapter 1505
119. of the Revised Code to determine whether the individual 1506
committed the act in question. Notice of an opportunity for a 1507
hearing shall be given in accordance with Chapter 119. of the 1508
Revised Code. If the board finds, pursuant to an adjudication held 1509
under this division, that the individual committed the act or if 1510
no hearing is requested, the board may order any of the sanctions 1511
identified under division (B) of this section.1512

       (I) The certificate to practice issued to an individual under 1513
this chapter and the individual's practice in this state are 1514
automatically suspended as of the date of the individual's second 1515
or subsequent plea of guilty to, or judicial finding of guilt of, 1516
a violation of section 2919.123 of the Revised Code, or the date 1517
the individual pleads guilty to, is found by a judge or jury to be 1518
guilty of, or is subject to a judicial finding of eligibility for 1519
intervention in lieu of conviction in this state or treatment or 1520
intervention in lieu of conviction in another jurisdiction for any 1521
of the following criminal offenses in this state or a 1522
substantially equivalent criminal offense in another jurisdiction: 1523
aggravated murder, murder, voluntary manslaughter, felonious 1524
assault, kidnapping, rape, sexual battery, gross sexual 1525
imposition, aggravated arson, aggravated robbery, or aggravated 1526
burglary. Continued practice after suspension shall be considered 1527
practicing without a certificate.1528

       The board shall notify the individual subject to the 1529
suspension by certified mail or in person in accordance with 1530
section 119.07 of the Revised Code. If an individual whose 1531
certificate is automatically suspended under this division fails 1532
to make a timely request for an adjudication under Chapter 119. of 1533
the Revised Code, the board shall do whichever of the following is 1534
applicable:1535

       (1) If the automatic suspension under this division is for a 1536
second or subsequent plea of guilty to, or judicial finding of 1537
guilt of, a violation of section 2919.123 of the Revised Code, the 1538
board shall enter an order suspending the individual's certificate 1539
to practice for a period of at least one year or, if determined 1540
appropriate by the board, imposing a more serious sanction 1541
involving the individual's certificate to practice.1542

       (2) In all circumstances in which division (I)(1) of this 1543
section does not apply, enter a final order permanently revoking 1544
the individual's certificate to practice.1545

       (J) If the board is required by Chapter 119. of the Revised 1546
Code to give notice of an opportunity for a hearing and if the 1547
individual subject to the notice does not timely request a hearing 1548
in accordance with section 119.07 of the Revised Code, the board 1549
is not required to hold a hearing, but may adopt, by an 1550
affirmative vote of not fewer than six of its members, a final 1551
order that contains the board's findings. In that final order, the 1552
board may order any of the sanctions identified under division (A) 1553
or (B) of this section.1554

       (K) Any action taken by the board under division (B) of this 1555
section resulting in a suspension from practice shall be 1556
accompanied by a written statement of the conditions under which 1557
the individual's certificate to practice may be reinstated. The 1558
board shall adopt rules governing conditions to be imposed for 1559
reinstatement. Reinstatement of a certificate suspended pursuant 1560
to division (B) of this section requires an affirmative vote of 1561
not fewer than six members of the board.1562

       (L) When the board refuses to grant a certificate to an 1563
applicant, revokes an individual's certificate to practice, 1564
refuses to register an applicant, or refuses to reinstate an 1565
individual's certificate to practice, the board may specify that 1566
its action is permanent. An individual subject to a permanent 1567
action taken by the board is forever thereafter ineligible to hold 1568
a certificate to practice and the board shall not accept an 1569
application for reinstatement of the certificate or for issuance 1570
of a new certificate.1571

       (M) Notwithstanding any other provision of the Revised Code, 1572
all of the following apply:1573

       (1) The surrender of a certificate issued under this chapter 1574
shall not be effective unless or until accepted by the board. 1575
Reinstatement of a certificate surrendered to the board requires 1576
an affirmative vote of not fewer than six members of the board.1577

       (2) An application for a certificate made under the 1578
provisions of this chapter may not be withdrawn without approval 1579
of the board.1580

       (3) Failure by an individual to renew a certificate of 1581
registration in accordance with this chapter shall not remove or 1582
limit the board's jurisdiction to take any disciplinary action 1583
under this section against the individual.1584

       (N) Sanctions shall not be imposed under division (B)(28) of 1585
this section against any person who waives deductibles and 1586
copayments as follows:1587

       (1) In compliance with the health benefit plan that expressly 1588
allows such a practice. Waiver of the deductibles or copayments 1589
shall be made only with the full knowledge and consent of the plan 1590
purchaser, payer, and third-party administrator. Documentation of 1591
the consent shall be made available to the board upon request.1592

       (2) For professional services rendered to any other person 1593
authorized to practice pursuant to this chapter, to the extent 1594
allowed by this chapter and rules adopted by the board.1595

       (O) Under the board's investigative duties described in this 1596
section and subject to division (F) of this section, the board 1597
shall develop and implement a quality intervention program 1598
designed to improve through remedial education the clinical and 1599
communication skills of individuals authorized under this chapter 1600
to practice medicine and surgery, osteopathic medicine and 1601
surgery, and podiatric medicine and surgery. In developing and 1602
implementing the quality intervention program, the board may do 1603
all of the following:1604

       (1) Offer in appropriate cases as determined by the board an 1605
educational and assessment program pursuant to an investigation 1606
the board conducts under this section;1607

       (2) Select providers of educational and assessment services, 1608
including a quality intervention program panel of case reviewers;1609

       (3) Make referrals to educational and assessment service 1610
providers and approve individual educational programs recommended 1611
by those providers. The board shall monitor the progress of each 1612
individual undertaking a recommended individual educational 1613
program.1614

       (4) Determine what constitutes successful completion of an 1615
individual educational program and require further monitoring of 1616
the individual who completed the program or other action that the 1617
board determines to be appropriate;1618

       (5) Adopt rules in accordance with Chapter 119. of the 1619
Revised Code to further implement the quality intervention 1620
program.1621

       An individual who participates in an individual educational 1622
program pursuant to this division shall pay the financial 1623
obligations arising from that educational program.1624

       Sec. 4731.228. (A) In accordance with division (B) of this 1625
section, the state medical board may suspend without a prior 1626
hearing a certificate to practice issued under this chapter to an 1627
individual who also holds a license as a terminal distributor of 1628
dangerous drugs with a pain management clinic classification 1629
issued under section 4729.552 of the Revised Code if the secretary 1630
and supervising member of the board determine that both of the 1631
following apply:1632

       (1) There is clear and convincing evidence that an employee 1633
of the pain management clinic has violated any provision of 1634
division (B) of section 4731.22 of the Revised Code.1635

       (2) The continued operation of the pain management clinic 1636
presents a danger of immediate and serious harm to others.1637

       (B) The secretary and supervising member shall provide 1638
written allegations to the board. The board, upon review of the 1639
allegations and by an affirmative vote of not less than six 1640
members, excluding the secretary and supervising member, may 1641
suspend the individual's certificate to practice without a prior 1642
hearing. A telephone conference call may be utilized for reviewing 1643
the allegations and taking a vote on the suspension.1644

       The board shall issue a written order of suspension under 1645
this section by certified mail or in person in accordance with the 1646
procedure for suspension without a prior hearing in section 119.07 1647
of the Revised Code. The order shall not be subject to suspension 1648
by the court during pendency of any appeal filed under section 1649
119.12 of the Revised Code.1650

       (C) An individual subject to an order under division (B) of 1651
this section may request an adjudicatory hearing. If the 1652
individual requests a hearing, the date set for the hearing shall 1653
be not less than fifteen days but not earlier than seven days 1654
after the individual first requests the hearing, unless otherwise 1655
agreed to by both the board and individual subject to the 1656
suspension.1657

       (D) Any summary suspension imposed under this section shall 1658
remain in effect, unless reversed on appeal, until a final 1659
adjudicative order issued by the board pursuant to Chapter 119. of 1660
the Revised Code becomes effective. The board shall issue its 1661
final adjudicative order within seventy-five days after completion 1662
of its hearing. A failure to issue the order within seventy-five 1663
days shall result in dissolution of the summary suspension but 1664
shall not invalidate any subsequent, final adjudicative order.1665

       Sec. 4731.241. The state medical board may solicit and accept 1666
grants and services from public and private sources for the 1667
purpose of developing and maintaining programs that address 1668
patient safety and education, supply and demand of health care 1669
professionals, and information sharing with the public and the 1670
individuals regulated by the board. The board shall not solicit or 1671
accept a grant or service that would interfere with the board's 1672
independence or objectivity, as determined by the board.1673

       All money received by the board under this section shall be 1674
deposited into the medical board education and patient safety 1675
fund, which is hereby created in the state treasury. The money 1676
deposited in the fund shall be used solely in accordance with this 1677
section.1678

       Sec. 4731.283. Not later than ninety days after the 1679
effective date of this section, theThe state medical board shall 1680
approve one or more continuing medical education courses of study 1681
included within the programs certified by the Ohio state medical 1682
association and the Ohio osteopathic association pursuant to 1683
section 4731.281 of the Revised Code that assist doctors of 1684
medicine and doctors of osteopathic medicine in diagnosing and 1685
treating intractablechronic pain, as defined in section 4731.052 1686
of the Revised Code.1687

       Sec. 4776.02. (A) An applicant for an initial license or 1688
restored license from a licensing agency, or a person seeking to 1689
satisfy the criteria for being a qualified pharmacy technician 1690
that are specified in section 4729.42 of the Revised Code, or a 1691
person seeking to satisfy the requirements to be an employee of a 1692
pain management clinic as specified in section 4729.552 of the 1693
Revised Code shall submit a request to the bureau of criminal 1694
identification and investigation for a criminal records check of 1695
the applicant or person. The request shall be accompanied by a 1696
completed copy of the form prescribed under division (C)(1) of 1697
section 109.572 of the Revised Code, a set of fingerprint 1698
impressions obtained as described in division (C)(2) of that 1699
section, and the fee prescribed under division (C)(3) of that 1700
section. The applicant or person shall ask the superintendent of 1701
the bureau of criminal identification and investigation in the 1702
request to obtain from the federal bureau of investigation any 1703
information it has pertaining to the applicant or person.1704

       An applicant or person requesting a criminal records check 1705
shall provide the bureau of criminal identification and 1706
investigation with the applicant's or person's name and address 1707
and, regarding an applicant, with the licensing agency's name and 1708
address.1709

       (B) Upon receipt of the completed form, the set of 1710
fingerprint impressions, and the fee provided for in division (A) 1711
of this section, the superintendent of the bureau of criminal 1712
identification and investigation shall conduct a criminal records 1713
check of the applicant or person under division (B) of section 1714
109.572 of the Revised Code. Upon completion of the criminal 1715
records check, the superintendent shall do whichever of the 1716
following is applicable:1717

       (1) If the request was submitted by an applicant for an 1718
initial license or restored license, report the results of the 1719
criminal records check and any information the federal bureau of 1720
investigation provides to the licensing agency identified in the 1721
request for a criminal records check;1722

       (2) If the request was submitted by a person seeking to 1723
satisfy the criteria for being a qualified pharmacy technician 1724
that are specified in section 4729.42 of the Revised Code or a 1725
person seeking to satisfy the requirements to be an employee of a 1726
pain management clinic as specified in section 4729.552 of the 1727
Revised Code, do both of the following:1728

       (a) Report the results of the criminal records check and any 1729
information the federal bureau of investigation provides to the 1730
person who submitted the request;1731

       (b) Report the results of the portion of the criminal records 1732
check performed by the bureau of criminal identification and 1733
investigation under division (B)(1) of section 109.572 of the 1734
Revised Code to the employer or potential employer specified in 1735
the request of the person who submitted the request and send a 1736
letter to that employer or potential employer regarding the 1737
information provided by the federal bureau of investigation that 1738
states either that based on that information there is no record of 1739
any conviction or that based on that information the person who 1740
submitted the request may not meet the criteria that are specified 1741
in section 4729.42 of the Revised Code, whichever is applicable.1742

       Sec. 4776.04. The results of any criminal records check 1743
conducted pursuant to a request made under this chapter and any 1744
report containing those results, including any information the 1745
federal bureau of investigation provides, are not public records 1746
for purposes of section 149.43 of the Revised Code and shall not 1747
be made available to any person or for any purpose other than as 1748
follows:1749

       (A) If the request for the criminal records check was 1750
submitted by an applicant for an initial license or restored 1751
license, as follows:1752

       (1) The superintendent of the bureau of criminal 1753
identification and investigation shall make the results available 1754
to the licensing agency for use in determining, under the agency's 1755
authorizing chapter of the Revised Code, whether the applicant who 1756
is the subject of the criminal records check should be granted a 1757
license under that chapter.1758

       (2) The licensing agency shall make the results available to 1759
the applicant who is the subject of the criminal records check.1760

       (B) If the request for the criminal records check was 1761
submitted by a person seeking to satisfy the criteria for being a 1762
qualified pharmacy technician that are specified in section 1763
4729.42 of the Revised Code or a person seeking to satisfy the 1764
requirements to be an employee of a pain management clinic as 1765
specified in section 4729.552 of the Revised Code, the 1766
superintendent of the bureau of criminal identification and 1767
investigation shall make the results available in accordance with 1768
the following:1769

       (1) The superintendent shall make the results of the criminal 1770
records check, including any information the federal bureau of 1771
investigation provides, available to the person who submitted the 1772
request and is the subject of the criminal records check.1773

       (2) The superintendent shall make the results of the portion 1774
of the criminal records check performed by the bureau of criminal 1775
identification and investigation under division (B)(1) of section 1776
109.572 of the Revised Code available to the employer or potential 1777
employer specified in the request of the person who submitted the 1778
request and shall send a letter of the type described in division 1779
(B)(2) of section 4776.02 of the Revised Code to that employer or 1780
potential employer regarding the information provided by the 1781
federal bureau of investigation that contains one of the types of 1782
statements described in that division.1783

       Section 2.  That existing sections 4723.481, 4729.071, 1784
4729.51, 4729.54, 4729.541, 4729.55, 4729.78, 4729.79, 4729.81, 1785
4729.82, 4729.99, 4731.052, 4731.22, 4731.283, 4776.02, and 1786
4776.04 of the Revised Code are hereby repealed.1787

       Section 3. Section 4731.22 of the Revised Code is presented 1788
in this act as a composite of the section as amended by Am. Sub. 1789
H.B. 280, Sub. H.B. 525, and Sub. S.B. 229 of the 127th General 1790
Assembly. The General Assembly, applying the principle stated in 1791
division (B) of section 1.52 of the Revised Code that amendments 1792
are to be harmonized if reasonably capable of simultaneous 1793
operation, finds that the composite is the resulting version of 1794
the section in effect prior to the effective date of the section 1795
as presented in this act.1796

feedback